应用血小板定位图识别外周动脉疾病中的性别二态性
这项前瞻性观察研究纳入107例接受下肢血运重建的外周动脉疾病患者,其中女性37例(34.6%),在术前、术后住院和术后门诊三个临床阶段进行血小板定位图检测。女性患者传统心血管危险因素患病率较低,但血小板反应性显著更高,且高血小板反应性与下肢血运重建后血栓形成发生率增加相关。
要点
- 女性患者血小板聚集更高(75.9 ± 23.3 vs 63.5 ± 28.8),血小板抑制更低(23.8 ± 23.4 vs 36.8 ± 28.9)。
- 按单抗和双抗治疗分层后,女性血小板聚集仍高于男性。
- 21例患者发生术后移植物/支架内血栓,其血小板定位图指标高于总体血小板聚集分布的第50百分位数。
核心结论
- 女性患者传统心血管危险因素患病率较低,但各临床阶段及抗血小板方案下血小板反应性均更高。
- 高血小板反应性与下肢血运重建后血栓形成发生率增加相关。
- 这些产生假设的发现为进一步探索外周动脉疾病患者的性别特异性凝血特征提供了基础。
研究设计与样本
- 前瞻性观察研究,纳入2020年12月至2022年1月期间诊断为外周动脉疾病并接受开放或腔内有名血管血运重建以重建流入道、流出道或两者的所有患者。
- 共纳入107例患者,其中女性37例(34.6%)。
- 患者临床随访血栓形成长达1年。
- 血小板定位图检测在三个临床阶段进行:术前、术后住院和术后门诊。
- 对女性和男性患者进行推断性分析,并使用与血栓形成相关的血小板定位图指标的四分位数分布推断血栓形成潜力。
主要发现
- 女性患者未控制糖尿病(2.7% vs 18.6%)、需要联合治疗的高血压(37.8% vs 58.6%)、慢性肾脏病(27.0% vs 51.4%)、冠状动脉疾病(29.7% vs 57.1%)和心肌梗死(16.2% vs 35.7%)发生率显著低于男性(均P < 0.05)。
- 女性患者血小板聚集显著更高(75.9 ± 23.3 vs 63.5 ± 28.8),血小板抑制显著更低(23.8 ± 23.4 vs 36.8 ± 28.9)(均P < 0.01)。
- 按术后住院和术后门诊临床阶段分层时,该趋势随时间保持一致。
- 两组抗血小板治疗使用无统计学 discernible 差异,但按药物方案类型分析时女性患者仍表现出更高的血小板反应性(单抗治疗血小板聚集:女性80.6 ± 21.0 vs 男性69.4 ± 25.0;双抗治疗血小板聚集:女性67.9 ± 23.8 vs 男性44.8 ± 31.8)(均P < 0.01)。
- 研究期间21例患者发生术后移植物/支架内血栓;相对于总体研究人群,血栓形成患者的血小板定位图指标高于总体血小板聚集分布的第50百分位数。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clinical outcomes in women with peripheral artery disease (PAD) after revascularization procedures are worse compared to men, yet there is little in the existing literature as why this may be the case. Platelet Mapping is an emerging point-of-care viscoelastic technology that measures the comprehensive properties of a blood clot, including fibrin-platelet interactions. This prospective observational study aimed to characterize the clinical and Platelet Mapping profiles of female and male patients undergoing lower extremity revascularization, and to correlate Platelet Mapping distribution to thrombotic potential. METHODS: All patients with a diagnosis of PAD undergoing named vessel open or endovascular revascularization to re-establish inflow, outflow, or both, during December 2020 and January 2022 were prospectively included. Patients were followed clinically for thrombosis for up to 1 year. Platelet Mapping assays were performed in 3 clinical phases: preoperative, postoperative inpatient, and postoperative outpatient. Inferential analysis between female and male patient was performed. The quartile distribution of Platelet Mapping metrics associated with thrombosis was used to infer to thrombotic potential. RESULTS: One hundred seven patients were enrolled, of which 37 (34.6%) were female. Female patients had significantly lower rates of uncontrolled diabetes (2.7% vs. 18.6%), hypertension requiring combination therapy (37.8% vs. 58.6%), chronic kidney disease (27.0% vs. 51.4%), coronary artery disease (29.7% vs. 57.1%), and myocardial infarction (16.2% vs. 35.7%) (all P < 0.05). Platelet reactivity was significantly higher in female patients with greater platelet aggregation (75.9 ± 23.3 vs. 63.5 ± 28.8) and lower platelet inhibition (23.8 ± 23.4 vs. 36.8 ± 28.9) (all P < 0.01). This trend was consistent over time when stratified by the postoperative inpatient and postoperative outpatient clinical phases. There was no statistically discernible difference in the use of antiplatelet therapy between groups, yet female patients continued to exhibit greater platelet reactivity when analyzed by the type of pharmacologic regimen (platelet aggregation on mono-antiplatelet therapy: 80.6 ± 21.0 in women versus 69.4 ± 25.0 in men; platelet aggregation on dual antiplatelet therapy: 67.9 ± 23.8 in women versus 44.8 ± 31.8 in men) (all P < 0.01). Twenty-one patients experienced postoperative graft/stent thrombosis within the study period. In relation to the overall study population, patients with thrombosis had Platelet Mapping metrics above the 50th percentile of overall platelet aggregation distribution. CONCLUSIONS: There is a growing appreciation for the differences in etiology, disease progression, and outcomes of cardiovascular conditions as they relate to sex. In this cohort, traditional cardiovascular risk factors were in lower prevalence in female patients. Platelet reactivity was found to be higher across clinical phases and antiplatelet regimens. High platelet reactivity was also associated with an increased incidence of thrombosis after lower extremity revascularization. These hypothesis-generating findings provide the basis for further exploration of sex-specific coagulation profiling in PAD patients.
引用
- Majumdar M, McElroy I, Waller HD, et al. Identifying Sex Dimorphism in Peripheral Artery Disease with Platelet Mapping. Ann Vasc Surg. 2022. PMID: 36058449. doi:10.1016/j.avsg.2022.08.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。